|
ACVR2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.531830E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.676000E-02 |
| Normal-vs-Stage2 |
7.284300E-02 |
| Normal-vs-Stage3 |
1.637730E-03 |
| Normal-vs-Stage4 |
2.139900E-03 |
| Stage1-vs-Stage2 |
6.848800E-01 |
| Stage1-vs-Stage3 |
6.631900E-02 |
| Stage1-vs-Stage4 |
8.362300E-02 |
| Stage2-vs-Stage3 |
4.086000E-01 |
| Stage2-vs-Stage4 |
2.613000E-01 |
| Stage3-vs-Stage4 |
5.761600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.619000E-03 |
| Normal-vs-AfricanAmerican |
3.648000E-01 |
| Normal-vs-Asian |
1.093220E-01 |
| Caucasian-vs-AfricanAmerican |
3.077000E-01 |
| Caucasian-vs-Asian |
2.646600E-01 |
| AfricanAmerican-vs-Asian |
7.280000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.550200E-02 |
| Normal-vs-Female |
1.033570E-02 |
| Male-vs-Female |
3.152000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.402000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.442800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.782700E-03 |
| Normal-vs-Age(81-100Yrs) |
6.176000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.359800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.626000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.807000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.266400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.105200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.831500E-02 |
| Classical-VS-Follicular |
8.217000E-01 |
| Classical-VS-Other |
8.456400E-01 |
| Classical-VS-Normal |
4.680200E-02 |
| Tall-VS-Follicular |
1.059590E-01 |
| Tall-VS-Other |
1.808820E-01 |
| Tall-VS-Normal |
2.399600E-03 |
| Follicular-VS-Other |
8.340400E-01 |
| Follicular-VS-Normal |
1.025010E-01 |
| Other-VS-Normal |
5.538800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.752200E-02 |
| Normal-vs-N1 |
1.701290E-03 |
| N0-vs-N1 |
2.082400E-01 |
|
|
